Showing items 1 - 10 of 10

Your selections:

Real-world treatment patterns and outcomes for patients with CLL using the Australian pharmaceutical benefits scheme (PBS) dataset

Patient Access to Medical Insurance Covered Orphan Drugs in China: Real-World Evidence From Patient Survey

Psychometric Evaluation of the Mandarin HeartQoL Health-Related Quality of Life Questionnaire Among Patients With Ischemic Heart Disease in China

Discrepancies between proxy estimates and patient reported, health related, quality of life: minding the gap between patient and clinician perceptions in heart failure

Can the direct medical cost of chronic disease be transferred across different countries? Using cost-of-illness studies on type 2 diabetes, epilepsy and schizophrenia as examples

Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings

Burden of disease studies in the Asia-Pacific Region: are there enough being performed to provide information for evidence-based health policy?

Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: a meta-analysis of randomized placebo-controlled trials

Cost-utility analysis of liraglutide versus glimepiride as add-on to metformin in type 2 diabetes patients in China

Health-related quality of life in Chinese patients with chronic prostatitis/chronic pelvic pain syndrome

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit